BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Anplag (Sarpogrelate) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Anplag (Sarpogrelate)\, from ClinicalTria
 ls.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06424548-1142@assetmemo.bio
DTSTAMP:20261121T005606Z
DTSTART;VALUE=DATE:20280630
DTEND;VALUE=DATE:20280701
SUMMARY:Anplag (Sarpogrelate): Phase na readout est. (NCT06424548)
DESCRIPTION:Anplag (Sarpogrelate)\, phase na\, Atherosclerotic Cardiovascul
 ar Disease.\nStudy: Comparison of the Improvement and Safety of the Ankle 
 Brachial Arterial Pressure Index of Sarpogrelate and Clopidogrel in Stroke
  Patients With Decreased Ankle Brachial Arterial Pressure Index and Interm
 ittent Claudication of Lower Limb Vascular Atherosclerosis.\nEstimated pri
 mary completion: 30 June 2028. This is a ClinicalTrials.gov estimate\, not
  a confirmed readout date\, and it can move.\nDrug page: https://assetmemo
 .bio/drug/sarpogrelate#upcoming-events\nRegistry record: https://clinicalt
 rials.gov/study/NCT06424548
URL:https://assetmemo.bio/drug/sarpogrelate#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
